Protecting blood vessel lining in severe infections
Treatments studied
Part of Infections clinical trials.
This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed or suspected infection, such as from bacteria or a virus.
- Your infection is severe enough to affect other organs, as measured by a standard score called SOFA (a score of 2 or higher).
- You are currently in the intensive care unit (ICU) or the emergency room and doctors expect you will need to be admitted to the ICU.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new approach to understand how sepsis (a severe infection) damages blood vessels. It looks at tiny particles released by cells and a protein called PLIN3 to see if they can help protect blood vessels in patients with sepsis.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
This study is testing a new way of measuring how much fluid leaks from your blood vessels during severe infection (septic shock). The goal is to help doctors decide how much fluid to give, which may improve recovery and prevent complications.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.